← All organizations

Forsight Vision4

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 1, 2014

Acquired by Roche on Jan 1, 2017

Timeline

2000s

Jan 1, 2005
Forsight Vision4— Founded

2010s

Jan 1, 2017
Roche— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

methotrexate

Phase 1 (1 own, 0 via acquisition)

ranibizumab

Indications

Studied for

Recent trials (3)

NCT02125266Lead sponsorPhase 1/Phase 2Apr 1, 2014
NCT01177644Lead sponsorPhase 1Jan 1, 2011
NCT01186432Lead sponsorPhase 1Aug 1, 2010

Details

Founded: Menlo Park, CA, US Jan 1, 2005
Last known activity: Apr 1, 2014